May 17, 2012
Bloomberg NewsEli Lilly and other big pharmaceutical companies are creating thousands of research jobs overseas as countries led by Singapore,
Ireland and South Africa boost incentives.
More
May 14, 2012
J.K. WallIndiana has taken “a giant step backward” in the availability of early-stage capital for life sciences companies,
according to the Indiana Health Industry Forum—which also has a few ideas on how to reverse those developments.
More
May 13, 2012
Bloomberg NewsTreatments for central nervous system diseases have a huge potential payoff, analysts say. A hint of whether the gamble may
pay off is due in the second half of this year, as Eli Lilly and Co. and Pfizer Inc. announce results for Alzheimer’s drugs
that attack the same protein as Roche’s experimental drug.
More
May 12, 2012
Entrepreneurship needs broader encouragement, and is targeted in a new plan.
More
April 30, 2012
J.K. WallBioCrossroads Inc. has raised an $8.25 million seed fund in its second attempt to help startup life sciences companies grow
to the point where they can attract venture capital or a corporate funder.
More
April 26, 2012
Associated PressIndiana-based orthopedic implant maker Zimmer Holdings Inc. on Thursday reported a fractional increase in first-quarter profit
on higher sales in all global regions, particularly the Asia Pacific.
More
April 26, 2012
J.K. WallSales at Indianapolis-based Dow AgroSciences grew 14 percent in the first quarter, to $1.8 billion, helped by an early planting
season in North America and a buoyant agricultural market.
More
April 19, 2012
Associated PressThe $38 million Lyles-Porter Hall will house numerous health programs. Purdue also is planning a $25 million Drug Discovery
Building that will bring together pharmaceutical researchers from throughout the school.
More
April 9, 2012
IBJ StaffBloomington-based medical device maker Cook Group has acquired General BioTechnology LLC, an Indianapolis biotech company
with about 20 employees, Cook Group announced Monday.
More
April 9, 2012
J.K. WallEli Lilly and Co.’s newest drug is a boon for Alzheimer’s research but is likely to bring the Indianapolis drugmaker
less than $100 million in annual sales—at least initially, according to one of the few analysts to make a forecast.
More
April 3, 2012
IBJ Staff and Bloomberg NewsWarsaw-based Biomet, which designs and manufactures orthopedic products for surgical and non-surgical uses, said the deal
would greatly expand its sports, extremities and trauma business.
More
March 29, 2012
IBJ StaffRoche Diagnostics Corp. plans to eliminate about 80 information technology jobs at its Indianapolis-area campus over the next
two years, the company said Thursday morning.
More
March 26, 2012
Associated PressIndiana-based Biomet Inc. has agreed to pay $22.7 million to settle U.S. criminal and civil allegations that it bribed government-employed
doctors in Argentina, Brazil and China for eight years to win business with hospitals.
More
March 26, 2012
J.K. WallTino Pereira, CEO of Canada-based Iotron Industries, discussed the electron-beam facility his company opened
March 15 in Columbia City, which lies halfway between Fort Wayne and Warsaw in northern Indiana. Iotron already helps some
of the orthopedic implant makers in Warsaw alter the strength, flexibility or surface conditions of the materials in the joint
replacements they make. That makes its services important in research and development for new products.
More
March 23, 2012
IBJ Staff and Associated Press, Associated PressEuropean regulators have approved an expanded use for the diabetes treatment Byetta, developed by Eli Lilly and Co. and Amylin
Pharmaceuticals Inc. The FDA approved the same expanded use last fall.
More
March 15, 2012
Noblesville-based Helmer Inc. said it will invest $10.6 million to build a new manufacturing and headquarters facility at
the Saxony Corporate Campus near Interstate 69. It plans to add the jobs by 2014.
More
March 13, 2012
J.K. WallEndocyte Inc. will submit its ovarian cancer drug EC145 for European market approval in the third quarter of this year after
the European Commission granted it orphan drug status.
More
March 2, 2012
IBJ StaffThe promotions of several executives follow the Indianapolis-based clinical testing company's announcement in January that
it was cutting jobs and restructuring its business.
More
February 25, 2012
Marc D. AllanArchitects were told to push the envelope and integrate. Be mindful of where you are in the city and integrate well.
More
February 18, 2012
IBJ StaffWe hate to think what Indiana’s economic future might be if no one had made a point of putting the state’s life
sciences assets to work in a coordinated, strategic way.
More
February 11, 2012
J.K. WallIn the 10 years BioCrossroads has been promoting life sciences in Indiana, the effort has netted more than 330 new companies,
an infusion of more than $330 million in venture capital, a tripling of exports, and a growing number of mentions in national
reports on life sciences.
More
February 6, 2012
J.K. WallIndiana companies landed just $14.1 million in venture funding last year, the lowest amount of capital flowing to the
state’s health care sector since BioEnterprises began tracking such deals in 2005.
More
February 2, 2012
IBJ Staff and Associated PressThe Indianapolis-based unit of Dow Chemical Co. saw earnings grow to $142 million, a fourth-quarter record and double the
$72 million reported for the 2010 period.
More
January 31, 2012
J.K. WallPatent expirations on Gemzar and Zyprexa contributed to the 27-percent earnings decline, but CEO John Lechleiter touted better-than-expected
sales of other products.
More
January 30, 2012
J.K. WallPurdue University's new Innovation and Commercialization Center is supposed to be a one-stop shop for professors to get help
developing their research into products and for outside investors to find out what research is taking place there.
More
we love that we were right in our predictions for the outcome of Tony's boondoggle. We aren't negative, we are positive that the league that never has will continue to blow chunks and stink up the place
I was initially excited to learn that this wasn't rubber-stamped, but if all that is required is to add some shrubs and some "window dressing" over the first floor of the garage, then I'd call it a waste of everyone's time. It should be noted that the Hearing Examiner is a DMD employee who reports to the same administrator as the DMD staff planner who recommended approval of the garage and whose report said that the requirement for ground-floor retail had been "satisfied". Better luck with appealing the inevitable approval at the MDC, where the commissioners are appointed by the Mayor, City Council, and County Commissioners, thus, presumably not all obligated to facilitate the administration's plans.
Wheat Thins, when paired with chocolate ice cream!
About the same.
New airport, new Lucas Oil Stadium, expanded convention center, $30,000,000 Pacer gift, Stupid City Way Project, Broad Ripple Parking Garage $ Giveaway, Money blown on lethal bike lanes. The list is endless..
We have complete morons in City Government with grafter buddies sitting in the wings also stealing parking meter revenue. Go to www.adavceindiana.com and read about Chicago Parking Meter Corruption.
It's all theft of taxpayer resources and complete lack of financial stewardship and devoid of integrity.
I would just like for basic city services please.